These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10916679)

  • 41. Hematologically important mutations: red cell pyruvate kinase (Third update).
    Bianchi P; Zanella A
    Blood Cells Mol Dis; 2000 Feb; 26(1):47-53. PubMed ID: 10772876
    [No Abstract]   [Full Text] [Related]  

  • 42. Red cell pyruvate kinase deficiency: molecular and clinical aspects.
    Zanella A; Fermo E; Bianchi P; Valentini G
    Br J Haematol; 2005 Jul; 130(1):11-25. PubMed ID: 15982340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The C1155G mutation of the red blood cell glucose-6-phosphate dehydrogenase gene in a subject with severe hereditary chronic nonspherocytic anaemia].
    Burzyńska B; Adamowicz-Salach A; Płochocka D; Gołaszewska E; Witos I
    Med Wieku Rozwoj; 2009; 13(2):136-9. PubMed ID: 19837994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An erythroid-specific exon is present in the human hexokinase gene.
    Ruzzo A; Andreoni F; Magnani M
    Blood; 1998 Jan; 91(1):363-4. PubMed ID: 9414310
    [No Abstract]   [Full Text] [Related]  

  • 45. Elevated pyruvate kinase activity in patients with hemolytic anemia due to red cell pyruvate kinase "deficiency".
    Beutler E; Forman L; Rios-Larrain E
    Am J Med; 1987 Nov; 83(5):899-904. PubMed ID: 3674096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hereditary nonspherocytic hemolytic anemia caused by a deficiency in erythrocytic hexokinase associated with glycogenosis of muscles].
    Badalian OL; Bondarenko ES; Ermil'chenko GV; Idel'son LI; Sitnikov VF; Kharit IO
    Klin Med (Mosk); 1970 Aug; 48(8):156-63. PubMed ID: 5273487
    [No Abstract]   [Full Text] [Related]  

  • 47. Red blood cell PK deficiency: An update of PK-LR gene mutation database.
    Canu G; De Bonis M; Minucci A; Capoluongo E
    Blood Cells Mol Dis; 2016 Mar; 57():100-9. PubMed ID: 26832193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Residual pyruvate kinase activity in PKLR-deficient erythroid precursors of a patient suffering from severe haemolytic anaemia.
    Klei TRL; Kheradmand Kia S; Veldthuis M; Beuger BM; Geissler J; Dehbozorgian J; Karimi M; van Bruggen R; van Zwieten R
    Eur J Haematol; 2017 Jun; 98(6):584-589. PubMed ID: 28295642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rabbit red blood cell hexokinase. Mechanism of decay during cell life-span.
    Magnani M; Stocchi V; Dacha M; Fornaini G
    Biomed Biochim Acta; 1983; 42(11-12):S311-6. PubMed ID: 6675710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hexokinase isoenzymes in normal erythrocytes of adults and newborns and in various hyperregenerative anemias].
    Tillmann W; Schröter W
    Klin Wochenschr; 1969 Jul; 47(14):772-8. PubMed ID: 5382557
    [No Abstract]   [Full Text] [Related]  

  • 51. The molecular basis of disorders of red cell enzymes.
    McMullin MF
    J Clin Pathol; 1999 Apr; 52(4):241-4. PubMed ID: 10474511
    [No Abstract]   [Full Text] [Related]  

  • 52. Novel pathogenic variant c.2714C>A (p. Thr905Lys) in the
    Dongerdiye R; Jagadeesh S; Suresh B; Rajendran A; Devendra R; Warang P; Kedar PS
    J Clin Pathol; 2021 Oct; 74(10):620-624. PubMed ID: 33361148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular characterisation of an Italian G6PD variant responsible for chronic non-spherocytic haemolytic anaemia.
    Martinez di Montemuros F; Cappellini MD; Dotti C; Tavazzi D; De Bellis G; Debernardi S; Fiorelli G
    Clin Genet; 1994 Nov; 46(5):357-9. PubMed ID: 7889645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pyruvate kinase deficiency.
    Miwa S
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1445-52. PubMed ID: 3328943
    [No Abstract]   [Full Text] [Related]  

  • 55. Human HKR isozyme: organization of the hexokinase I gene, the erythroid-specific promoter, and transcription initiation site.
    Murakami K; Kanno H; Miwa S; Piomelli S
    Mol Genet Metab; 1999 Jun; 67(2):118-30. PubMed ID: 10356311
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Red cell pyruvate kinase deficiency: adverse effect of oral contraceptives.
    Kendall AG; Charlow GF
    Acta Haematol; 1977; 57(2):116-20. PubMed ID: 402766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional organization and evolution of mammalian hexokinases: mutations that caused the loss of catalytic activity in N-terminal halves of type I and type III isozymes.
    Tsai HJ
    Arch Biochem Biophys; 1999 Sep; 369(1):149-56. PubMed ID: 10462451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Red cell phosphoglycerate kinase deficiency. A new cause of non-spherocytic hemolytic anemia.
    Kraus AP; Langston MF; Lynch BL
    Biochem Biophys Res Commun; 1968 Jan; 30(2):173-7. PubMed ID: 4230542
    [No Abstract]   [Full Text] [Related]  

  • 59. A new glucose-6-phosphate dehydrogenase variant (G6PD Iwate) associated with congenital non-spherocytic hemolytic anemia.
    Kanno H; Takano T; Fujii H; Tani K; Morisaki T; Hirono A; Kumakawa T; Ogura H; Takahashi K; Tsutsumi H
    Nihon Ketsueki Gakkai Zasshi; 1988 Jul; 51(4):715-9. PubMed ID: 3201886
    [No Abstract]   [Full Text] [Related]  

  • 60. Study of the molecular defects in pyruvate kinase deficient patients affected by nonspherocytic hemolytic anemia.
    Baronciani L; Magalhães IQ; Mahoney DH; Westwood B; Adekile AD; Lappin TR; Beutler E
    Blood Cells Mol Dis; 1995; 21(1):49-55. PubMed ID: 7655861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.